Citation map · Study

Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.

0 references·16 citing·50 second hopsampled

this work references cited by second hop· second hop is a sample of the most-cited connections

References

No references inside the corpus for this window.

Cited by

2008World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision862 cited
2009Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant Trials204 cited
2016A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive–compulsive disorder in children/adolescents and adults132 cited
2000Multicenter Double-blind Comparison of Sertraline and Desipramine for Concurrent Obsessive-Compulsive and Major Depressive Disorders127 cited
1992Pharmacotherapy of Obsessive-Compulsive Disorder118 cited
2003Obsessive-compulsive spectrum disorders117 cited
2006A Randomized Clinical Trial of Cognitive-Behavioral Group Therapy and Sertraline in the Treatment of Obsessive-Compulsive Disorder110 cited
2003A Review of Pharmacologic Treatments for Obsessive-Compulsive Disorder108 cited
2015Reporting Bias in Clinical Trials Investigating the Efficacy of Second-Generation Antidepressants in the Treatment of Anxiety Disorders101 cited
1997A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder91 cited
1999Placebo-Controlled, Multicenter Study of Sertraline Treatment for Obsessive-Compulsive Disorder84 cited
1993The Psychopharmacology of Obsessive Compulsive Disorder: Implications for Treatment and Pathogenesis

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work